Xollent Biotech's Unattributed Round

Xollent Biotech raised a round of funding on May 17, 2018.

Xollent Bio develops novel therapeutics for cardiovascular diseases and regeneration medicines. Its target audience includes scientists and venture capitalists.…

Articles about Xollent Biotech's Unattributed Round: